Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.

Saved in:
Bibliographic Details
Title: Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Authors: Wong GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Zhou J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bin Liu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Xu D; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA., Schumacher SE; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Puschhof J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McFarland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Zou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dulak A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Surface Oncology, Cambridge, MA, USA., Henderson L; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA., Xu P; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA., O'Day E; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA., Rendak R; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA., Liao WL; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA., Cecchi F; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA., Hembrough T; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA., Schwartz S; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA., Szeto C; OncoPlex Diagnostics/NantOmics, Rockville, MD, USA., Rustgi AK; Division of Gastroenterology, Departments of Medicine and Genetics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wong KK; Department of Medicine, Harvard Medical School, Boston, MA, USA.; NYU Langone Health, New York, NY, USA., Diehl JA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Jensen K; Sanofi Oncology, Cambridge, MA, USA.; University of Illinois at Urbana-Champaign, Chicago, IL, USA., Graziano F; Department of Biomolecular Sciences, University of Urbino 'Carlo Bo', Urbino, Italy., Ruzzo A; Department of Biomolecular Sciences, University of Urbino 'Carlo Bo', Urbino, Italy., Fereshetian S; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mertins P; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Max Delbrück Center for Molecular Medicine, Berlin, Germany., Carr SA; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Beroukhim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Nakamura K; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Watanabe M; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.; Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Baba H; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan., Imamura Y; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.; Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Catenacci D; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA. dcatenac@bsd.uchicago.edu., Bass AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. adam_bass@dfci.harvard.edu.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. adam_bass@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. adam_bass@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. adam_bass@dfci.harvard.edu.
Source: Nature medicine [Nat Med] 2018 Oct; Vol. 24 (10), pp. 1627.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-018-0168-6